Unibest

Pharmaceutical intermediates

Varenicline Tartrate Intermediates

4 pharmaceutical intermediates for Varenicline Tartrate. Indication: Nicotine dependence; Smoking cessation; Smoking.

提交项目All intermediates

About Varenicline Tartrate

Originator
Pfizer Inc
Indication
Nicotine dependence; Smoking cessation; Smoking
Approved Date
05/10/2006

Available intermediates

4 intermediates currently listed for Varenicline Tartrate. Request specifications, documentation or a quotation for any item below.

Varenicline Tartrate intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
1,4-DIHYDRO-1,4-METHANONAPHTHALENE4453-90-1//
2,3,4,5-TETRAHYDRO-1H-1,5-METHANO-3-BENZAZEPINE HYDROCHLORIDE230615-52-8//
2,3,4,5-Tetrahydro-7,8-dinitro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine230615-59-5//
2,3,4,5-Tetrahydro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine-7,8-diamine230615-69-7//

Other programs under V

Valbenazine Tosylate (NBI-98854)VelpatasvirVenetoclaxVericiguatVibegronVilazodone HydrochlorideVONOPRAZAN FUMARATEVoxelotor

Building toward Varenicline Tartrate?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →